Cargando…
Endocannabinoids and Schizophrenia
The endocannabinoids anandamide and 2-arachydonoylglycerol (2-AG) are lipids naturally derived from membrane precursors which bind cannabinoid receptors (CB(1), CB(2)). This endocannabinoid system is disturbed in schizophrenia. Indeed, there seems to be an association between schizophrenia and polym...
Autores principales: | Desfossés, Joëlle, Stip, Emmanuel, Bentaleb, Lahcen Ait, Potvin, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034083/ http://dx.doi.org/10.3390/ph3103101 |
Ejemplares similares
-
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2012) -
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case–Control Trial with Quetiapine
por: Zhornitsky, Simon, et al.
Publicado: (2011) -
Relationships between Brain Structure and Metabolic Changes in Schizophrenia Patients Treated with Olanzapine: A Voxel-Based Morphometric Study
por: Letourneau, Genevieve, et al.
Publicado: (2011) -
Markedly Reduced Thermal Pain Perception in a Schizoaffective Patient with Tardive Dyskinesia
por: Potvin, Stéphane, et al.
Publicado: (2016) -
The Neural Correlates of Mental Rotation Abilities in Cannabis-Abusing Patients with Schizophrenia: An fMRI Study
por: Potvin, Stéphane, et al.
Publicado: (2013)